Eli Lilly And reported $221.02B in Market Capitalization for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbott ABT:US $ 209.42B 3.44B
Abbvie ABBV:US $ 190.63B 8.32B
ALKERMES ALKS:US 4.98B 1.04B
Amgen AMGN:US $ 120.75B 19.29B
AstraZeneca AZN:LN 138.77B 24.78B
Astrazeneca AZN:US 186.95B 29.34B
Baxter International BAX:US $ 40.21B 271.8M
Biogen BIIB:US $ 42.17B 9.96B
Bristol Myers Squibb BMY:US $ 131.34B 17.15B
Catalent CTLT:US $ 22.74B 4.32B
Coherus Biosciences CHRS:US $ 1.23B 181.38M
Drreddys Laboratories RDY:US 10.92B 1.18B
Eli Lilly And LLY:US $ 221.02B 902.49M
Endo International Ordinary Shares ENDP:US 756.54M 335.33M
Gilead Sciences GILD:US $ 87.58B 1.22B
GlaxoSmithKline GSK:LN 70.63B 794.04M
Glaxosmithkline GSK:US 95.15B 3.61B
Horizon Pharma HZNP:US 24.74B 3.7B
Intercept Pharmaceuticals ICPT:US $ 493.04M 169.99M
JAZZ PHA JAZZ:US 7.99B 2.84B
Johnson & Johnson JNJ:US $ 425145.86M 8679.8M
Lannett LCI:US $ 126.83M 66.72M
Medtronic MDT:US 168.7B 1.88B
Merk MRK:US $ 190131.55M 6786.63M
Neurocrine Biosciences NBIX:US $ 9.08B 123.68M
Novartis NOVN:VX 187.04B 20.99B
Novartis NVS:US 200.79B 24.12B
Perrigo Ordinary Shares PRGO:US 6.33B 205.5M
Pfizer PFE:US $ 241143.67M 21937.97M
Phibro Animal Health PAHC:US $ 872.45M 297.3M
Prestige Brands PBH:US $ 2.81B 200.74M
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Revance Therapeutics RVNC:US $ 2B 126.68M
Sanofi SAN:FP 104.97B 6.43B
Sanofi SNY:US 121.56B 10.5B
Teva Pharmaceutical Industries TEVA:US 10.85B 134.37M
United Therapeutics UTHR:US $ 8.29B 249.36M
Zoetis ZTS:US $ 91.85B 3.38B